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Purpose: To compare the diagnostic performance of automated imaging for glaucoma.
Design: Prospective, direct comparison study.
Participants: Adults with suspected glaucoma or ocular hypertension referred to hospital eye services in the
United Kingdom.
Methods: We evaluated 4 automated imaging test algorithms: the Heidelberg Retinal Tomography (HRT; Heidel-
berg Engineering, Heidelberg, Germany) glaucoma probability score (GPS), the HRT Moorﬁelds regression analysis
(MRA), scanning laser polarimetry (GDx enhanced corneal compensation; Glaucoma Diagnostics (GDx), Carl Zeiss
Meditec, Dublin, CA) nerve ﬁber indicator (NFI), and Spectralis optical coherence tomography (OCT; Heidelberg Engi-
neering) retinal nerve ﬁber layer (RNFL) classiﬁcation. We deﬁned abnormal tests as an automated classiﬁcation of
outsidenormal limits forHRTandOCTorNFI 56 (GDx).Weconductedasensitivity analysis, usingborderline abnormal
image classiﬁcations. The reference standard was clinical diagnosis by a masked glaucoma expert including stan-
dardized clinical assessment and automated perimetry. We analyzed 1 eye per patient (the one with more advanced
disease). We also evaluated the performance according to severity and using a combination of 2 technologies.
Main Outcome Measures: Sensitivity and speciﬁcity, likelihood ratios, diagnostic, odds ratio, and propor-
tion of indeterminate tests.
Results: We recruited 955 participants, and 943 were included in the analysis. The average age was 60.5 years
(standard deviation, 13.8 years); 51.1% were women. Glaucoma was diagnosed in at least 1 eye in 16.8%; 32% of
participants had no glaucoma-related ﬁndings. The HRT MRA had the highest sensitivity (87.0%; 95% conﬁdence
interval [CI], 80.2%e92.1%), but lowest speciﬁcity (63.9%; 95% CI, 60.2%e67.4%); GDx had the lowest sensitivity
(35.1%; 95% CI, 27.0%e43.8%), but the highest speciﬁcity (97.2%; 95% CI, 95.6%e98.3%). The HRT GPS
sensitivity was 81.5% (95% CI, 73.9%e87.6%), and speciﬁcity was 67.7% (95% CI, 64.2%e71.2%); OCT sensi-
tivity was 76.9% (95% CI, 69.2%e83.4%), and speciﬁcity was 78.5% (95% CI, 75.4%e81.4%). Including only eyes
with severe glaucoma, sensitivity increased: HRT MRA, HRT GPS, and OCT would miss 5% of eyes, and GDx would
miss 21% of eyes. A combination of 2 different tests did not improve the accuracy substantially.
Conclusions: Automated imaging technologies can aid clinicians in diagnosing glaucoma, butmay not replace
current strategies because they can miss some cases of severe glaucoma. Ophthalmology 2016;123:930-
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See Editorial on page 926.Diagnosis of glaucoma by an experienced ophthalmologist
remains the best reference standard.1 However, diagnosis can
be challenging, especially in people with early glaucoma.
Accurate clinical diagnosis of glaucoma is limited by
subjectivity, reliance on the examiner’s experience, and a
wide variation of optic disc structure among the population.1,2
Automated imaging of the optic nerve head or retinal
nerve ﬁber layer (RNFL) increasingly is being introduced
into practice for diagnosis and monitoring.3 Interpretation of930 Crown Copyright  2016 Published by ELSEVIER Inc. on behalf of Americ
Academy of Ophthalmology
This is an open access article under the Open Government Licence (OGL) (h
www.nationalarchives.gov.uk/doc/open-government-licence/version/3/)some of the outputs may require expertise, but classiﬁcation
of results as normal or abnormal also can be generated by
automatic comparison with a normative database.
Several imaging technologies that quantify the structure of
the retina and optic nerve head can be used in glaucoma.4
Confocal scanning laser ophthalmoscopy is commercially
available as Heidelberg retina tomograph (HRT; Heidelberg
Retina Tomograph III [Heidelberg Engineering, Heidelberg,
Germany]). It includes 2 classiﬁcation algorithms, thean
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probability score (GPS).6,7 The RNFL can be assessed using
either scanning laser polarimetry, currently available as the
GDx-PRO (Glaucoma Diagnostics [GDx] Carl Zeiss Meditec,
Dublin, CA)8 or spectral-domain optical coherence tomogra-
phy (OCT), with several commercial devices available.9 These
imaging tests are user friendly and provide automated
quantitative classiﬁcations.10
Although many published data describe the diagnostic
performance of imaging techniques in cohorts of retrospec-
tively selected glaucoma patients or glaucoma-free normal
subjects, there is no high-quality evidence of the compara-
tive accuracy of current imaging techniques for identifying
glaucoma in consecutive patients with unknown status
screened for possible glaucoma.4,11 Existing data from case-
control studies may not be applicable to the clinically rele-
vant population who undergo assessment and diagnosis.12
We aimed to assess and compare the performance of these
commercially available technologies to detect glaucoma in
a prospective cohort. This work was conducted as part of a
wider publicly funded study (National Institute for Health
Research Health Technology Assessment [HTA], 09/22/
111) that also evaluated cost-effectiveness of these imag-
ing technologies in a triage setting in the United Kingdom.
Methods
Study Design and Participants
We conducted a pragmatic multicenter, within-patient, comparative
evaluation of the diagnostic accuracy of automated imagingTable 1. Possible Diagnoses by the Clinician Performing the Ref
Diagnosis
Glaucoma
Severe Evidence of glaucomatous optic neuropath
Moderate Evidence of glaucomatous optic neuropath
and e12 dB
Mild Evidence of glaucomatous optic neuropath
Glaucoma suspect
Disc suspect Appearance suggestive of glaucomatous op
normal visual ﬁelds (with or without h
Visual ﬁeld suspect Visual ﬁeld loss suggestive of glaucoma, b
of the optic disc (with or without high
Visual ﬁeld and disc
suspect
Both the optic disc and visual ﬁeld have
of normal (with or without high IOP)
Ocular hypertension Both the visual ﬁeld and optic nerve appe
Primary angle closure Closed anterior chamber angle (apposition
>21 mmHg and presence of peripheral
Primary angle-closure
suspect
Closed anterior chamber angle (apposition
visual ﬁeld and optic nerve appear norm
No glaucoma-related
ﬁndings
Absence of any of the above diagnoses
IOP ¼ intraocular pressure; MD ¼ mean deviation.
*Any of the following: optic disc or retinal nerve ﬁber layer structural abnorma
especially at the inferior or superior poles; documented, progressive thinning of t
diffuse or localized abnormalities of the peripapillary retinal nerve ﬁber layer, esp
ﬁber layer hemorrhages; and optic disc neural rim asymmetry of the 2 eyes con
yReliable visual ﬁeld abnormality considered a valid representation of the subjec
layer damage (e.g., nasal step, arcuate ﬁeld defect, or paracentral depression in c
other hemiﬁeld, that is, across the horizontal midline (in early or moderate castechniques for diagnosis of glaucoma, the Glaucoma Automated
Tests Evaluation (GATE). We selected participants prospectively,
and they underwent imaging with all technologies under evaluation
and then had the reference standard diagnosis (clinical assessment
by a glaucoma expert, including examination of the fundus by
biomicroscopy and visual ﬁeld testing with Humphrey 24-2
Swedish interactive threshold algorithm testing, masked to the
imaging test results). The study was approved by the North of
Scotland Research Ethics Committee (reference, 10/S0801/58) and
was conducted according to the tenets of the Declaration of Hel-
sinki. The full study protocol is publicly available.13 We sought
patient views on the design, conduct, and analysis of the study
through representatives from the International Glaucoma Society.
The study was coordinated from a central study ofﬁce in the
Health Services Research Unit, University of Aberdeen, and was
conducted in 5 National Health Service hospital eye services in the
United Kingdom (Aberdeen, Bedford, Hinchingbrooke, Liverpool,
and Moorﬁelds). We identiﬁed eligible patients from their referral
letter as being adults (age 18 years) who were newly
referred from primary care to the department of ophthalmology of
the recruiting hospital with a possible glaucoma diagnosis or
glaucoma-related ﬁnding. This included high intraocular pressure;
possible abnormalities in the optic disc, visual ﬁeld test results, or
both; and possible narrow anterior chamber angle. Patients were
ineligible if they had a previous diagnosis of glaucoma or had
already been seen by an ophthalmologist.Participant Recruitment Process
We sent information about the study to potential eligible patients at
each recruiting hospital, before their ﬁrst hospital appointment. At
their ﬁrst clinic appointment, we then approached patients, and
those patients who agreed to participate and signed the consenterence Standard Measurement, Ranked in Order of Severity
Deﬁnition
y* and a characteristic visual ﬁeld lossy with MD of e12.01 dB or worse
y* and a characteristic visual ﬁeld lossy with MD between e6.01 dB
y* and a characteristic visual ﬁeld lossy with MD of e6 dB or better
tic neuropathy, but also may represent a variation of normality, with
igh IOP)
ut also may represent a variation of normality, with normal appearance
IOP)
some features that resemble glaucoma, but also may represent a variation
ar normal in the presence of elevated pressure >21 mmHg
ally or synechial) in at least 270 and at least 1 of the following 2: IOP
anterior synechiae; both visual ﬁeld and optic nerve appear normal
ally without any synechiae) in at least 270, with IOP 21 mmHg; both
al
lities; diffuse thinning, focal narrowing, or notching of the optic disc rim,
he neuroretinal rim with an associated increase in cupping of the optic disc;
ecially at the inferior or superior poles; disc rim or peripapillary retinal nerve
sistent with loss of neural tissue.
t’s functional status. Visual ﬁeld damage consistent with retinal nerve ﬁber
lusters of test sites). Visual ﬁeld loss in 1 hemiﬁeld that is different from the
es). Absence of other known explanations.
931
Figure 1. Flow diagram showing diagnosis of the cohort. FN ¼ false negative; FP ¼ false positive; GPS ¼ glaucoma probability score; HRT ¼ Heidelberg
retinal tomography; MRA ¼ Moorﬁelds regression analysis; OCT ¼ optical coherence tomography; TN ¼ true negative; TP ¼ true positive.
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Banister et al  Diagnostic Accuracy of Glaucoma Imagingform were enrolled. We recorded the demographics (age, gender)
of those patients who declined to take part.
Testing Regimen
Before seeing the ophthalmologist, participants were imaged us-
ing all imaging tests in a random order followed by visual ﬁeld
measurement with standard automated perimetry with the Hum-
phrey 24-2 Swedish interactive threshold algorithm strategy. An
ophthalmologist with glaucoma expertise (reference standard)
who was masked to the imaging results then assessed partici-
pants. We conducted all tests on the same day in 2 centers, and in
3 centers, the clinician assessment was on a separate date, within
2 weeks.
Index Tests
The following imaging technologies were compared.
Heidelberg Retina Tomograph III. A confocal laser scanning
ophthalmoscope (Heidelberg Retina Tomograph III; Heidelberg
Engineering) measures quantitative structural information of the
optic disc anatomy and creates a topographic map of the retinal
surface. Images are given a quality index (the mean topography
standard deviation), which the manufacturer recommends should
be less than 40 mm. We assessed 2 classiﬁcation tools: the MRA
and the GPS. Both methods produced an overall classiﬁcation of
within normal limits, borderline, or outside normal limits by
comparison with normative data. Abnormal index test results for
MRA and GPS were deﬁned as an overall classiﬁcation of outside
normal limits.
Scanning Laser Polarimetry. Scanning laser polarimetry (the
GDx with enhanced corneal compensation or the GDx PRO; Carl
Zeiss Meditec) analyzes polarized light reﬂected from the fundus to
measure the RNFL thickness. Images are given a quality index Q,
which the manufacturer recommends should be 7 or more. The
software generated an automated discriminating classiﬁer of
glaucoma, the nerve ﬁber indicator (NFI) value. The manufacturers
report that 95% of the normal population has an NFI value of 35 or
less and that 99% of the normal population has an NFI value of 55
or less.14 An abnormal index test result for the GDx was taken as
an NFI value of 56 or more. An NFI value between 36 and 55 was
considered to be similar to the borderline category of the other
imaging tests. Measurements were obtained using either the GDx
PRO or GDx variable corneal compensation (VCC) with an
updated enhanced corneal compensation module.
Optical Coherence Tomography. Spectral-domain OCT was
performed using the Spectralis (Heidelberg Engineering), which
produces a detailed cross-sectional image of the retina using re-
ﬂected light in a similar manner to B-mode ultrasound. Images
are given a quality index Q, which the manufacturer recommends
should be more than 15. The software (RNFL software version 5)
automatically compared an average RNFL thickness with a
normative database and produced an overall classiﬁcation of
within normal limits, borderline, or outside normal limits.
Abnormal index test results for OCT were taken as a classiﬁca-
tion of outside normal limits.
We classed images as good quality if they met the manu-
facturer quality threshold as described above. Pupils were not
dilated routinely unless image quality was inadequate. Between
1 and 3 experienced technicians performed the imaging tests at
each center. We did not have any restriction on the same tech-
nician performing all imaging tests on an individual. The im-
aging technologies automatically generated a classiﬁcation
measurement without user input, except the HRT MRA,
which required manual identiﬁcation of the margin of the optic
disc.Reference Standard
An ophthalmologist with glaucoma expertise performed a clinical
assessment that formed the reference standard (Table 1). All
glaucoma experts participating in the study were trained in the
procedures and used a preagreed deﬁnition of glaucoma
(Table 1). Clinical examination included Goldmann applanation
tonometry, gonioscopy, biomicroscopic examination of the
optic disc (pupils dilated unless contraindicated), and evaluation
of the visual ﬁeld test with Humphrey Swedish interactive
threshold algorithm 24-2. This represents currently
recommended clinical practice in the United Kingdom.15
Imaging test results were not available to the ophthalmologist.
If a clinical diagnosis could not be established, (e.g., unreliable
visual ﬁeld measurement), an inconclusive diagnosis was
recorded. To ensure a valid and consistent application of the
agreed reference standard, a limited number of consultant
ophthalmologists provided the assessment (n ¼ 11) according
to the diagnosis chart shown in Table 1.
Outcomes
Primary outcomes were sensitivity and speciﬁcity. Secondary
outcomes were diagnostic odds ratio, likelihood ratio, and pro-
portion of indeterminate test results.
Sample Size
We calculated the sample size using a 5% signiﬁcance level based
on a 2-sided test using standard diagnostic accuracy study
methods.16 A study of 897 individuals would have 90% power to
detect a 9% difference in accuracy for the primary outcome of
diagnosis of glaucoma based on conservative assumptions (a
probability of disagreement of 0.18, a glaucoma rate of 25%, and
a sensitivity of 86%).11 This sample size also would yield 80%
power for detecting a 6% difference in accuracy should the
sensitivity be 93% (the current best estimate from meta-analyses
of high-quality diagnostic studies). For speciﬁcity, there would
be more than 90% power to detect a 5% difference. We assumed
that 6% of test results would be indeterminate, and this increased
the total sample size to 954.
Statistical Analysis
We included a single eye per patient in the analysis. We ranked the
clinical diagnosis in order of decreasing severity according to
Table 1. We used the worst eye based on this ranking for our
analyses. When both eyes had the same diagnosis, we chose an
eye at random. We calculated diagnostic measures (sensitivity,
speciﬁcity, likelihood ratios, and diagnostic odds ratio) for each
test for detection of glaucoma. We compared the diagnostic
performance (sensitivity and speciﬁcity) of the imaging tests
using McNemar’s test16 and generated corresponding 95% paired
conﬁdence intervals (CIs).17 We did not impute any missing
data. We reported an indeterminate result when no automatic
classiﬁcation was generated, imaging quality was low, or an
artifact was present. We explored the following using sensitivity
analyses: performance of the tests across the spectrum of disease,
classifying borderline test results as abnormal, combining results
of more than one imaging test, and considering glaucoma
suspects as glaucoma. In combining test results, if either test
gave abnormal results, we classiﬁed this as abnormal. We only
classiﬁed combined results as normal if results from both tests
were normal. We calculated the area under the receiver operating
characteristic curve (ROC) for each test using the global
parameter for HRT or OCT and the NFI parameter for GDx, and
we compared these using the method of DeLong et al.18 We933
Table 3. Diagnosis of Participants’ Worse Eye by Clinician in
Secondary Care (Reference Standard)
Diagnosis by Clinician
Worse Eye
No. %
Ophthalmology Volume 123, Number 5, May 2016have reported the results according to the Standards for Reporting
Diagnostic accuracy studies (STARD) guidelines.19 We conducted
a post hoc analysis, suggested by a peer reviewer, to explore
informally the difference in test performance between tests by
calculating individual recruiting center sensitivity and speciﬁcity
(results not reported here).Number of eyes 932
Glaucoma (reference standard positive test results) 158 17.0
Mild 78 8.4
Moderate 45 4.8
Severe 26 2.8
Severity not recorded 9 1.0
Disc suspect 170 18.2
VF suspect 36 3.9
VF þ disc suspect 36 3.9
OHT 115 12.3
PAC 31 3.3
PAC suspect 83 8.9Results
We recruited 966 participants (48% of those approached) between
April 2011 and July 2013. After obtaining informed consent, we
excluded 11 participants: 10 were ineligible (preexisting glaucoma,
n ¼ 4; referred from other ophthalmologist, n ¼ 4; or not referred
for glaucoma, n ¼ 2), and 1 person withdrew from the study.
Therefore, 955 participants were available for the index test
comparison. Imaging was not implemented for all index tests in 12Table 2. Participant Demographics and Ocular Characteristics
Characteristic
Value
All Participants Glaucoma Nonglaucoma
No. 943 158 770
Mean age (SD), yrs 60.5 (13.8) 67.4 (12.7) 59.2 (13.6)
Female gender, no.
(%)
482 (51.1) 74 (46.8) 401 (52.1)
Ethnicity, no. (%)*
Black or black
Caribbean
25 (2.7) 4 (2.5) 21 (2.7)
Black or black
British-African
20 (2.1) 6 (3.8) 14 (1.8)
Asian or Asian
British-Indian
18 (1.9) 5 (3.2) 13 (1.7)
Asian or Asian
British-Pakistani
4 (0.4) 0 (0) 4 (0.5)
Chinese 1 (0.1) 1 (0.6) 0 (0)
Other Asian
background
4 (0.4) 1 (0.6) 3 (0.4)
Mixed white and
black African
1 (0.1) 1 (0.6) 0 (0)
White British 826 (89.2) 140 (88.6) 686 (89.1)
Other 29 (3.1) 0 (0) 29 (3.8)
Right Eye Left Eye
Refraction
Mean sphere D,
Mean (SD), n
0.4 (3.3), 571 1.0 (3.6), 561
Myopia greater
than e5 D,
N/n (%)
37/943 (3.9) 36/943 (3.8)
Hyperopia greater
than þ5 D, N/n
(%)
38/943 (4.0) 51/943 (5.4)
Astigmatism
greater
than 3 D, N/n
(%)
16/943 (1.7) 16/943 (1.7)
Visual acuity
logMAR, Mean
SD, n
0.0 (0.30), 925 0.0 (0.3), 926
D ¼ diopter; logMAR ¼ logarithm of the minimum angle of resolution;
SD ¼ standard deviation.
*Self-reported ethnicity; no ethnicity was recorded for 15 participants.
No glaucoma-related ﬁndings 299 32.1
Inconclusive diagnosis 4 0.4
OHT ¼ ocular hypertension; PAC ¼ primary angle closure; VF ¼ visual
ﬁeld.
934participants, and these were excluded from all analyses. There were
no adverse events reported during the study. Figure 1 shows a ﬂow
diagram of participant ﬂow and classiﬁcation of results by test and
reference standard. The baseline demographics and ocular
characteristics of the 943 participants who underwent all index
tests are shown in Table 2. Age and gender of nonparticipants
were similar to those of participants (see Fig 1).
In 11 of the 943 participants who underwent all the imaging
tests, no reference standard was collected (Fig 1). Reference
standard results (diagnosis by clinician) of the remaining 932
participants’ worse eyes (as described in “Methods”) are shown
in Table 3. Table 4 (available at www.aaojournal.org) shows
intraocular pressure and visual ﬁeld mean deviation according to
diagnosis. The most common diagnosis was no glaucoma-related
ﬁndings (32% of participants had no glaucoma-related ﬁndings
in either eye). Glaucoma was diagnosed in at least 1 eye in 17% of
the cohort, and 6.6% had glaucoma in both eyes at referral. Most
eyes that were diagnosed with glaucoma had primary open-angle
glaucoma (78%).
The distribution of test results, including indeterminate rates, is
shown in Table 5 (available at www.aaojournal.org). Indeterminate
rates were low (<10%) for all index tests; OCT had the lowest rate
of indeterminate test results (4.2%). Indeterminate test results
(including those with low quality) were not included in the
primary analysis.
Figure 1 shows the categorization of the test results according to
the reference standard ﬁnding (true and false positive, true and false
negative). Of the 943 participants for whom all 4 tests were
performed, 158 were classiﬁed by the clinician as glaucoma and
770 as not glaucoma. No conclusive diagnosis could be made for 4
participants. Table 6 (available at www.aaojournal.org) shows the
diagnostic performance of the 4 tests, including CIs. The HRT
MRA had the highest sensitivity (87.0%) but the lowest speciﬁcity
(63.9%); GDx had the lowest sensitivity (35.1%) but the highest
speciﬁcity (97.2%); and the other 2 tests provided intermediate
results (HRT GPS values were very similar to the HRT MRA
results, and OCT had very similar sensitivity and speciﬁcity
values). The diagnostic odds ratio ranged from 9.24 for HRT GPS
to 18.48 for GDx. Table 7 (available at www.aaojournal.org)
shows the paired comparison of the 4 imaging tests.
Figure 2. Graph showing the sensitivity and speciﬁcity of the tests across the spectrum of disease. GPS ¼ glaucoma probability score; HRT ¼ Heidelberg
retinal tomography; MRA ¼ Moorﬁelds regression analysis; OCT ¼ optical coherence tomography.
Banister et al  Diagnostic Accuracy of Glaucoma ImagingWe explored with sensitivity analyses the performance of the
tests across the spectrum of disease by excluding mild or moderate
glaucoma diagnoses, or both, as shown in Figure 2. Restricting the
reference standard to a diagnosis of severe glaucoma yielded very
high sensitivity (95%) for HRT MRA, HRT GPS, and OCT; of
these 3, OCT demonstrated the highest speciﬁcity (71%).Figure 3. Graph showing comparison of the sensitivity and speciﬁcity of the t
included as abnormal test results, compared with test results of outside normal
tomography; MRA ¼ Moorﬁelds regression analysis; NFI ¼ nerve ﬁber indicatWe also explored the effect of including a borderline classiﬁ-
cation as an abnormal index test in addition to outside normal
limits results, shown in Figure 3. Figure 4 (available at
www.aaojournal.org) shows the categorization ﬂow diagram for
the analysis in Figure 3. Sensitivity was higher for all tests than
under the default analysis, but with correspondingly lowerests when test results classiﬁed as borderline or outside normal limits were
limits only. GPS ¼ glaucoma probability score; HRT ¼ Heidelberg retinal
or; OCT ¼ optical coherence tomography.
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both being able to rule in and out the presence of glaucoma for
all 4 imaging tests (CIs did not contain 1.0). The positive
likelihood ratio for GDx was substantially higher than for the
other tests (less than 5). This was because of the very high
speciﬁcity that more than offset the lower relative sensitivity
performance. The diagnostic odds ratios ranged from 7.36 for
GDx to 14.62 for HRT MRA. Table 8 (available at
www.aaojournal.org) shows a further analysis of the diagnostic
performance of the imaging tests when glaucoma suspect cases
as well as glaucoma cases were classiﬁed as cases of disease for
the reference standard.
Figure 5 (available at www.aaojournal.org) shows the receiver
operating characteristics (ROC) curves for each test under the
default analysis. The areas under the ROC curve were similar, with
OCT having the highest (0.84) and MRA the lowest (0.79). There
was no statistical evidence of a difference between them (P¼ 0.077).
We further explored the diagnostic accuracy of using combi-
nations of tests (Table 9; available at www.aaojournal.org). The
HRT MRA was combined with the other 3 tests to form a
combined test. Combining tests in this way increased the
sensitivity as expected, but only marginally, and at the expense
of a greater decrease in speciﬁcity. Finally, the post hoc informal
exploration of center differences showed some indication of
MRA speciﬁcity varying between centers.Discussion
The GATE study was a large, prospective, within-patient,
comparative diagnostic accuracy study that provided the
sensitivity and speciﬁcity data of 4 diagnostic imaging tests
for glaucoma. In our study, most participants had successful
testing and all 4 imaging tests had some value in terms of
diagnosing or ruling out glaucoma. The HRT MRA had the
highest sensitivity, but lower speciﬁcity, compared with
other tests. By contrast, GDx had the best speciﬁcity,
although the lowest sensitivity. The HRT GPS results were
similar to those of the HRT MRA, as might be anticipated
given that their analysis is based on imaging the same
structure (i.e., the optic disc), and this ﬁnding has been
reported previously in different populations.6 Sensitivity for
OCT was of very similar magnitude to its speciﬁcity. Most
tests conducted yielded good-quality automated test results,
between 92% (GDx) and 97% (OCT). Optical coherence
tomography had the lowest percentage of low-quality
imaging results and GDx had the highest, according to the
image quality classiﬁcation provided in the device software.
There also was a small percentage of cases (<5%) in which
an automated imaging test result could not be produced.
A number of sensitivity analyses were carried out to assess
the robustness of the ﬁndings of the primary analysis. The
HRT MRA had consistently the highest sensitivity across
most analyses, but at a cost of lower speciﬁcity comparedwith
other tests. When excluding cases of mild glaucoma, HRT
GPS had higher sensitivity than HRT MRA. For severe
glaucoma, OCT had the highest sensitivity and speciﬁcity. By
contrast, GDx had the highest speciﬁcity, but the lowest
sensitivity, across all analyses. None of the imaging tests had a
sensitivity of 100% in identifying severe glaucoma.
Varying the test deﬁnition of abnormal imaging test re-
sults by including the borderline category as positive results936had the anticipated impact of improving the detection of
glaucoma, although at the expense of more nonglaucoma
cases being classiﬁed falsely as being cases of glaucoma.
Using combinations of 2 imaging tests led to a marginal
improvement in the detection of glaucoma and a reduction
in the number of indeterminate test results. Because the
HRT GPS and HRT MRA analyses consistently gave the
best performing sensitivity and both methods are available
on the same machine (HRT), an increase in HRT perfor-
mance in terms of sensitivity could be obtained by assigning
a diagnosis of glaucoma when either the HRT GPS or HRT
MRA classiﬁcations were outside normal limits. However,
the improvement was smaller than the loss in performance
in terms of correctly identifying nondisease cases. Consid-
ering the additional cost and practical implications,
including training and the purchase of additional equipment,
suggests that the use of a single technology is to be
preferred. The informal exploration of test performance by
center suggested that HRT MRA may vary slightly more in
this regard. However, there were likely to be some differ-
ences between centers in terms of population, which may
explain this, or alternatively, it may be a chance ﬁnding.
Although the automated imaging classiﬁcations performed
well at identifying disease (sensitivity), they did not perform
as well in identifying normal cases (speciﬁcity). The excep-
tion to this was GDx, which had very poor sensitivity but
moderate speciﬁcity. The choice ofwhich imaging test is to be
preferred to aid diagnosis reﬂects the inherent trade-off
regarding diagnostic testing, where the desire not to miss
glaucomawhen present must be balanced against the desire to
identify correctly those who are without disease.
Among the strengths of this study is the fact that the
enrolled population included consecutive recruitment of
subjects without a known history of disease, which reﬂects a
potential clinical application of a diagnostic test. Patients
were referred from community optometrists, and this gives a
representative sample of current UK practice. The recruited
cohort included a large percentage of patients without dis-
ease as well as those across the spectrum of glaucoma,
including glaucoma suspects and those with ocular hyper-
tension. Prevalence of glaucoma in this cohort was nearly
20%. Other reported studies evaluating the performance of
these diagnostic technologies often have used patients
already diagnosed with glaucoma, with patients already
identiﬁed as normal, which has a risk of selection bias. A
previous head-to-head comparison of the best-performing
parameters of previous versions of the imaging devices the
Heidelberg Retina Tomograph II, GDx VCC, and Stratus
OCT found similar performance across techniques among a
prospective sample of glaucoma patients compared with
healthy volunteers.20 However, the sample did not represent
routine practice (i.e., when the disease status is unknown),
and the technologies have been upgraded since.
The tests that we compared are all routinely available in
clinical practice, and each provided an automated classiﬁ-
cation of glaucoma status. By using the automated outputs,
there is no need to interpret the large number of images and
parameters that are produced by the technologies, and this
therefore may be attractive to clinicians who are not glau-
coma experts. An additional strength of our study is that we
Banister et al  Diagnostic Accuracy of Glaucoma Imagingused a paired design in which participants underwent all 4
tests, allowing a head-to-head comparison. We chose as the
reference standard the clinical assessment provided by
different ophthalmologists with glaucoma expertise. All
ophthalmologists were trained in the study protocols and
agreed to a common set of criteria to deﬁne glaucoma and
normality and were masked to the imaging test results when
making their diagnosis. By using different ophthalmologists
working at different units, the results of the study are more
likely to be generalizable than results from studies per-
formed in a single unit.
Among the limitations, we recognize that diagnosing
glaucoma during the very early stage of disease is chal-
lenging. Although consensus was sought through structured
discussions and agreement, some assessor differences may
have remained between the centers. Ideally, a longitudinal
follow-up would provide the best possible reference stan-
dard. This was proposed by Medeiros et al.21 who used optic
nerve head progression on stereophotographic examination
as the criterion for glaucoma diagnosis. We used a single
eye (worse diagnosis) per patient, and assessment of the
presence of glaucoma in either eye may have a slightly
different diagnostic performance. A limitation of the HRT
MRA analysis is that it requires a trained technician to
identify manually the margins of the optic disc on the
acquired image, and this may affect the diagnostic
performance if it is not carried out appropriately by a
trained examiner. There are other OCT instruments in
clinical use with glaucoma diagnostic capabilities, and the
results of this study using the Spectralis device may not
be applicable fully to other OCT technologies. In this
study, we analyzed only a small amount of potential data
generated. In addition, OCT hardware and software are
evolving rapidly, and new developments may improve
their diagnostic performance. Also, current OCT
technology now is able to quantify macular parameters
that may be useful to diagnose glaucoma, for example, in
myopia.
The results of this study have implications for clinical
practice. No test demonstrated or could have been expected
to demonstrate 100% sensitivity and speciﬁcity, and less-
than-perfect results reﬂect a combination of factors that
include an imperfect reference standard and normative da-
tabases, at least in part because of the variability of normal
anatomic features and instrument operatoredependent fac-
tors. Thus, relying solely on the automatic classiﬁcation to
diagnose glaucoma or using this as a replacement for visual
ﬁeld testing is not recommended. We suggest automated
imaging technologies are best suited as an adjunct to the
ophthalmologist’s assessment. It should also be noted that
the clinical biomicroscopic examination of the optic nerve
and nerve ﬁber layer yields a true stereoscopic view of the
structures that may reveal glaucomatous features that are not
visible in the computer-generated images from the imaging
technologies used in this study, such as optic disc hemor-
rhages. These imaging instruments probably have their
greatest usefulness when assisting in the diagnosis of more
subtle glaucomatous optic neuropathy, particularly in situ-
ations where the nerve ﬁber layer and optic disc are indis-
tinct clinically. Additionally, there is a role to assistclinicians who may not be glaucoma specialists or in the
case of trainees where the additional information provided
by these devices can be a valuable component of training.
From a UK perspective, using automated imaging classiﬁ-
cation of imaging technologies as a triage test may prove to
be cost-effective.22
In conclusion, this study offers valuable insight into the
comparative diagnostic performance of automated diag-
nostic tests using some of their outputs (disc classiﬁcation
for HRT and RNFL classiﬁcation for GDx enhanced corneal
compensation and Spectralis OCT) that are easy to read and
interpret and are encountered in a real-life setting. Auto-
mated testing is helpful in and aids glaucoma diagnosis.
However, reliance solely on imaging (as used in this study)
as a means of diagnosis is not recommended because some
patients with severe glaucoma may be missed.
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